IDEAS home Printed from https://ideas.repec.org/a/bla/jorssb/v82y2020i5p1223-1247.html
   My bibliography  Save this article

An information theoretic approach for selecting arms in clinical trials

Author

Listed:
  • Pavel Mozgunov
  • Thomas Jaki

Abstract

The question of selecting the ‘best’ among different choices is a common problem in statistics. In drug development, our motivating setting, the question becomes, for example, which treatment gives the best response rate. Motivated by recent developments in the theory of context‐dependent information measures, we propose a flexible response‐adaptive experimental design based on a novel criterion governing treatment arm selections which can be used in adaptive experiments with simple (e.g. binary) and complex (e.g. co‐primary, ordinal or nested) end points. It was found that, for specific choices of the context‐dependent measure, the criterion leads to a reliable selection of the correct arm without any parametric or monotonicity assumptions and provides noticeable gains in settings with costly observations. The asymptotic properties of the design are studied for different allocation rules, and the small sample size behaviour is evaluated in simulations in the context of phase II clinical trials with different end points. We compare the proposed design with currently used alternatives and discuss its practical implementation.

Suggested Citation

  • Pavel Mozgunov & Thomas Jaki, 2020. "An information theoretic approach for selecting arms in clinical trials," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 82(5), pages 1223-1247, December.
  • Handle: RePEc:bla:jorssb:v:82:y:2020:i:5:p:1223-1247
    DOI: 10.1111/rssb.12391
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/rssb.12391
    Download Restriction: no

    File URL: https://libkey.io/10.1111/rssb.12391?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. D. Magirr & T. Jaki & J. Whitehead, 2012. "A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection," Biometrika, Biometrika Trust, vol. 99(2), pages 494-501.
    2. Williamson, S. Faye & Jacko, Peter & Villar, Sofía S. & Jaki, Thomas, 2017. "A Bayesian adaptive design for clinical trials in rare diseases," Computational Statistics & Data Analysis, Elsevier, vol. 113(C), pages 136-153.
    3. M. Clertant & J. O’Quigley, 2017. "Semiparametric dose finding methods," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 79(5), pages 1487-1508, November.
    4. repec:bla:biomet:v:71:y:2015:i:4:p:969-978 is not listed on IDEAS
    5. David Azriel & Micha Mandel & Yosef Rinott, 2010. "The Treatment Versus Experimentation Dilemma in Dose-finding Studies," Discussion Paper Series dp559, The Federmann Center for the Study of Rationality, the Hebrew University, Jerusalem.
    6. James E. Barrett, 2016. "Information-adaptive clinical trials: a selective recruitment design," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 65(5), pages 797-808, November.
    7. Beibei Guo & Yisheng Li & Ying Yuan, 2016. "A dose–schedule finding design for phase I–II clinical trials," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 65(2), pages 259-272, February.
    8. Nolan A. Wages & Mark R. Conaway & John O'Quigley, 2011. "Continual Reassessment Method for Partial Ordering," Biometrics, The International Biometric Society, vol. 67(4), pages 1555-1563, December.
    9. Pavel Mozgunov & Thomas Jaki, 2019. "An information theoretic phase I–II design for molecularly targeted agents that does not require an assumption of monotonicity," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 68(2), pages 347-367, February.
    10. Adam L. Smith & Sofía S. Villar, 2018. "Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints," Journal of Applied Statistics, Taylor & Francis Journals, vol. 45(6), pages 1052-1076, April.
    11. P. Mozgunov & T. Jaki & M. Gasparini, 2019. "Loss functions in restricted parameter spaces and their Bayesian applications," Journal of Applied Statistics, Taylor & Francis Journals, vol. 46(13), pages 2314-2337, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Helen Yvette Barnett & Sofía S. Villar & Helena Geys & Thomas Jaki, 2023. "A novel statistical test for treatment differences in clinical trials using a response‐adaptive forward‐looking Gittins Index Rule," Biometrics, The International Biometric Society, vol. 79(1), pages 86-97, March.
    2. Alisjahbana, Irene & Graur, Andrei & Lo, Irene & Kiremidjian, Anne, 2022. "Optimizing strategies for post-disaster reconstruction of school systems," Reliability Engineering and System Safety, Elsevier, vol. 219(C).
    3. Williamson, S. Faye & Jacko, Peter & Jaki, Thomas, 2022. "Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses," Computational Statistics & Data Analysis, Elsevier, vol. 174(C).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sean M. Devlin & Alexia Iasonos & John O’Quigley, 2021. "Phase I clinical trials in adoptive T‐cell therapies," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 70(4), pages 815-834, August.
    2. Helen Yvette Barnett & Sofía S. Villar & Helena Geys & Thomas Jaki, 2023. "A novel statistical test for treatment differences in clinical trials using a response‐adaptive forward‐looking Gittins Index Rule," Biometrics, The International Biometric Society, vol. 79(1), pages 86-97, March.
    3. Williamson, S. Faye & Jacko, Peter & Jaki, Thomas, 2022. "Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses," Computational Statistics & Data Analysis, Elsevier, vol. 174(C).
    4. Stephen E. Chick & Noah Gans & Özge Yapar, 2022. "Bayesian Sequential Learning for Clinical Trials of Multiple Correlated Medical Interventions," Management Science, INFORMS, vol. 68(7), pages 4919-4938, July.
    5. Kasianova, Ksenia & Kelbert, Mark & Mozgunov, Pavel, 2021. "Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measures," Computational Statistics & Data Analysis, Elsevier, vol. 158(C).
    6. Chunyan Cai & Ying Yuan & Yuan Ji, 2014. "A Bayesian dose finding design for oncology clinical trials of combinational biological agents," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 63(1), pages 159-173, January.
    7. Azriel, David, 2014. "Optimal sequential designs in phase I studies," Computational Statistics & Data Analysis, Elsevier, vol. 71(C), pages 288-297.
    8. Yan‐Cheng Chao & Thomas M. Braun & Roy N. Tamura & Kelley M. Kidwell, 2020. "A Bayesian group sequential small n sequential multiple‐assignment randomized trial," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 69(3), pages 663-680, June.
    9. Koichi Hashizume & Jun Tshuchida & Takashi Sozu, 2022. "Flexible use of copula‐type model for dose‐finding in drug combination clinical trials," Biometrics, The International Biometric Society, vol. 78(4), pages 1651-1661, December.
    10. Nigel Stallard & Peter K Kimani, 2018. "Uniformly minimum variance conditionally unbiased estimation in multi-arm multi-stage clinical trials," Biometrika, Biometrika Trust, vol. 105(2), pages 495-501.
    11. Beibei Guo & Suyu Liu, 2018. "Optimal Benchmark for Evaluating Drug-Combination Dose-Finding Clinical Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 10(1), pages 184-201, April.
    12. Pranab Ghosh & Lingyun Liu & P. Senchaudhuri & Ping Gao & Cyrus Mehta, 2017. "Design and monitoring of multi‐arm multi‐stage clinical trials," Biometrics, The International Biometric Society, vol. 73(4), pages 1289-1299, December.
    13. Waverly Wei & Xinwei Ma & Jingshen Wang, 2023. "Fair Adaptive Experiments," Papers 2310.16290, arXiv.org.
    14. Jeffrey A. Mills & Gary Cornwall & Beau A. Sauley & Jeffrey R. Strawn, 2018. "Improving the Analysis of Randomized Controlled Trials: a Posterior Simulation Approach," BEA Working Papers 0157, Bureau of Economic Analysis.
    15. Jonathan Legare & Ping Yao & Victor S. Y. Lo, 2023. "A case for conducting business-to-business experiments with multi-arm multi-stage adaptive designs," Journal of Marketing Analytics, Palgrave Macmillan, vol. 11(3), pages 490-502, September.
    16. Pavel Mozgunov & Rochelle Knight & Helen Barnett & Thomas Jaki, 2021. "Using an Interaction Parameter in Model-Based Phase I Trials for Combination Treatments? A Simulation Study," IJERPH, MDPI, vol. 18(1), pages 1-19, January.
    17. Monia Ezzalfani, 2019. "How to design a dose-finding study on combined agents: Choice of design and development of R functions," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-24, November.
    18. Sofía S. Villar & William F. Rosenberger, 2018. "Covariate†adjusted response†adaptive randomization for multi†arm clinical trials using a modified forward looking Gittins index rule," Biometrics, The International Biometric Society, vol. 74(1), pages 49-57, March.
    19. Azriel, David, 2012. "A note on the robustness of the continual reassessment method," Statistics & Probability Letters, Elsevier, vol. 82(5), pages 902-906.
    20. Márcio A. Diniz & Sungjin Kim & Mourad Tighiouart, 2020. "A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades," Stats, MDPI, vol. 3(3), pages 1-18, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:jorssb:v:82:y:2020:i:5:p:1223-1247. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://edirc.repec.org/data/rssssea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.